Sanofi

Digital & AI

How Are Digital and AI Supporting Our Value Chain?


Our Latest Stories

Aurora Loh, a biotechnologist in protective gear, inspecting large-scale machinery at Sanofi Modulus Singapore.

Our Science

October 8, 2025

Modulus: Redefining the Future of Biopharma Manufacturing

United by Purpose

Each of us plays a unique role in bringing our purpose to life.

About Us

Who We Are

We are an R&D driven,
AI-powered biopharma company committed to improving people’s lives and creating compelling growth.

Our Pipeline

5

Therapeutic areas

82

Compounds in clinical development

24

Clinical trials in phase 3

Pursue Progress. Discover Extraordinary. 

Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.

Our Latest Press Releases


October 8, 2025
Press Release: AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors

September 24, 2025
Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation

September 24, 2025
Press release: Availability of the Q3 2025 Aide mémoire

September 23, 2025
Press Release: Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1